Low Frequency of ER-α A908G Mutation in Breast Tumors
Author Information
Author(s): Conway Kathleen, Parrish Eloise, Edmiston Sharon N, Tolbert Dawn, Tse Chiu-Kit, Geradts Joseph, Livasy Chad A, Singh Harsharan, Newman Beth, Millikan Robert C
Primary Institution: University of North Carolina, Chapel Hill, NC, USA
Hypothesis
Does the ER-α A908G mutation occur in invasive breast tumors?
Conclusion
The study confirms the presence of the ER-α A908G mutation in invasive breast tumors, particularly in higher-grade tumors.
Supporting Evidence
- The ER-α A908G mutation was detected in 37 of 653 (5.7%) breast tumors.
- The mutation was found more frequently in higher-grade breast tumors.
- The absence of this mutation in germline DNA confirmed it to be somatic.
- Mixed lobular/ductal tumors had a higher prevalence of the mutation.
Takeaway
This study looked at breast tumors to see if a specific mutation was present. They found it in a small number of tumors, especially in those that were more aggressive.
Methodology
The study screened 653 invasive breast tumors for the ER-α A908G mutation using SSCP analysis and 33P-cycle sequencing.
Limitations
The study is based on a relatively small number of mutation-positive tumors.
Participant Demographics
Participants included African American and white women aged 20 to 74 years.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI 1.09 to 7.34
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website